Bücher liefern wir in Deutschland versandkostenfrei
Persönliche Beratung +49 (30) 839 003 0 Newsletter Service & Hilfe

Age-related Macular Degeneration

From Clinic to Genes and Back to Patient Management

Noch nicht erschienen, ca. Mai 2022. Liefertermin 1-3 Tage nach Erscheinen

Print-Ausgabe

2022


This edited book focuses on the recent advances in our understanding of age-related macular degeneration (AMD), combining epidemiology and clinical diagnosis, with genetics and immunological aspects as well as the role of proteostasis and mitochondria before diving into new therapies including stem cell based approaches.

AMD is a leading cause of largely incurable blindness worldwide and projected to double from 2.07 million to 5.44 million individuals by 2050 in the United States. Globally, 288 million individuals are projected to have AMD by 2040. The disease has enormous socioeconomic impact on the affected individuals, their families and the society. This book will bring together the state of the art basic science knowledge with clinically relevant findings and address the challenges for future research in AMD. The intersection of different disciplines will provide potential areas for further investigations to reduce the burden of blindness from AMD.

This book offers an appealing and insightful resource for clinicians, scientists, students and fellows.

Combines epidemiology, clinical diagnosis with genetics and cell biology

Explores immunological aspects

Dives into new therapy approaches such as stem cells
Zurück zum Seitenanfang